Literature DB >> 9649655

Linear IgA disease and ulcerative colitis.

C De Simone1, C Guerriero, R Pellicano.   

Abstract

Linear IgA disease is an acquired bullous disease of the skin characterized by linear IgA deposits along the dermal-epidermal junction. Inflammatory bowel diseases have been rarely reported in association with linear IgA disease. We have recently observed a patient suffering from ulcerative colitis who developed a cutaneous bullous eruption that was diagnosed as a linear IgA disease. Foreign antigens penetrating the inflamed bowel mucosa might give rise to the production of autoantibodies cross-reacting with the cutaneous antigens involved in the pathogenesis of linear IgA disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649655

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  5 in total

1.  Linear IgA bullous dermatosis: an association with ulcerative colitis versus renal cell carcinoma.

Authors:  A Scott Keller; Molly B Bouldin; Lisa A Drage; Stephen C Hauser; Mark D P Davis
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

2.  [Linear IgA disease with ocular involvement associated with ulcerative colitis].

Authors:  A Klein; S M Wenzel; E M Messmer; M Landthaler; T Vogt
Journal:  Hautarzt       Date:  2010-01       Impact factor: 0.751

3.  Linear IgA dermatosis after infliximab infusion for ulcerative colitis.

Authors:  Kelli D Bryant; Matthew J DeNunzio; Michael J Ford
Journal:  JAAD Case Rep       Date:  2016-12-05

4.  Linear IgA dermatosis associated with ulcerative colitis: complete and sustained remission after total colectomy.

Authors:  Thiago Jeunon de Sousa Vargas; Mônica Fialho; Luiza Tavares dos Santos; Palmira Assis de Jesus Barreto Rodrigues; Ana Luisa Bittencourt Sampaio Jeunon Vargas; Maria Auxiliadora Jeunon Sousa
Journal:  An Bras Dermatol       Date:  2013 Jul-Aug       Impact factor: 1.896

Review 5.  Humoral Epitope Spreading in Autoimmune Bullous Diseases.

Authors:  Dario Didona; Giovanni Di Zenzo
Journal:  Front Immunol       Date:  2018-04-17       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.